Isabel Santamarina

528 citations
10 papers · 402 indexed · h-index 8
Topics
Cancer Cells and Metastasis (5 papers)Cancer-related molecular mechanisms research (3 papers)Cancer Research and Treatments (2 papers)
Partner nations
Spain

In The Last Decade

Isabel Santamarina

10 papers receiving 393 citations

Peers

Isabel Santamarina
Comparison fields: 5 of 50
  • Molecular Biology 283
  • Cancer Research 221
  • Oncology 84
  • Surgery 68
  • Genetics 43
Replace Xueqiang Ding with:
Xueqiang Ding China
Ángela Pollán Spain
Christine F. O’Neill United States
Kazuhiro Hagikura Japan
Guanming Lu China
Samuel D. Rose United States
Jian Xie China
Tian Liang China
Katayoon Pakravan Iran
Yoshitaka Tajima Japan
Isabel Santamarina relative to Xueqiang Ding China Xueqiang Ding's profile →
Citations per field
00.5×2.8×
Xueqiang Ding · 1×
Citations per year

Countries citing papers authored by Isabel Santamarina

Since Specialization
Citations

This map shows the geographic impact of Isabel Santamarina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Santamarina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Santamarina more than expected).

Fields of papers citing papers by Isabel Santamarina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Santamarina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Santamarina. The network helps show where Isabel Santamarina may publish in the future.

Co-authorship network of co-authors of Isabel Santamarina

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Santamarina. A scholar is included among the top collaborators of Isabel Santamarina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Santamarina. Isabel Santamarina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 28
2 10
3 78
4 134
5 41
6 3
7 19
8 28
9 59
10 2

About Isabel Santamarina

Isabel Santamarina is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 10 papers that have together received 402 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (221 citations), Molecular Biology (283 citations) and Genetics (43 citations). Isabel Santamarina has collaborated with scholars based in Spain. Frequent co-authors include Manuel Valladares‐Ayerbes, María José Lorenzo-Patiño, Angélica Figueroa, Mar Haz‐Conde, Luis Antón-Aparicio, M. Blanco, Lourdes Calvo, Margarita Reboredo, Juan Fernández‐Tajes and María Quindós. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026